Publicacions en què col·labora amb Eva Ardanaz Aicua (13)

2020

  1. Endocrine treatment and incidence of relapse in women with oestrogen receptor-positive breast cancer in Europe: a population-based study

    Breast Cancer Research and Treatment, Vol. 183, Núm. 2, pp. 439-450

2018

  1. Cancer survival in adult patients in Spain. Results from nine population-based cancer registries

    Clinical and Translational Oncology, Vol. 20, Núm. 2, pp. 201-211

  2. Circulating metabolites associated with alcohol intake in the european prospective investigation into cancer and nutrition cohort

    Nutrients, Vol. 10, Núm. 5

  3. Interplay between genetic predisposition, macronutrient intake and type 2 diabetes incidence: analysis within EPIC-InterAct across eight European countries

    Diabetologia, Vol. 61, Núm. 6, pp. 1325-1332

2017

  1. A combination of plasma phospholipid fatty acids and its association with incidence of type 2 diabetes: The EPIC-InterAct case-cohort study

    PLoS Medicine, Vol. 14, Núm. 10

  2. Cancer incidence in Spain, 2015

    Clinical and Translational Oncology, Vol. 19, Núm. 7, pp. 799-825

  3. Fruit and vegetable intake and prostate cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC)

    International Journal of Cancer, Vol. 141, Núm. 2, pp. 287-297

  4. Inflammatory potential of the diet and mortality in the Spanish cohort of the European Prospective Investigation into Cancer and Nutrition (EPIC-Spain)

    Molecular Nutrition and Food Research, Vol. 61, Núm. 8

  5. The association between adult attained height and sitting height with mortality in the European prospective investigation into cancer and nutrition (EPIC)

    PLoS ONE, Vol. 12, Núm. 3

2016

  1. Investigation of gene–diet interactions in the incretin system and risk of type 2 diabetes: the EPIC-InterAct study

    Diabetologia, Vol. 59, Núm. 12, pp. 2613-2621

  2. Main nutrient patterns and colorectal cancer risk in the European Prospective Investigation into Cancer and Nutrition study

    British Journal of Cancer, Vol. 115, Núm. 11, pp. 1430-1440

  3. Modifiable causes of premature death in middle-age in Western Europe: Results from the EPIC cohort study

    BMC Medicine, Vol. 14, Núm. 1

2015

  1. Global surveillance of cancer survival 1995-2009: Analysis of individual data for 25 676 887 patients from 279 population-based registries in 67 countries (CONCORD-2)

    The Lancet, Vol. 385, Núm. 9972, pp. 977-1010